Please assess the completion status of the following clinical trial:

Trial Title: Open Label Study Telmisartan and Amlodipine in Hypertension

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. patients aged at least 18 years~2. diagnosis of essential hypertension and blood pressure not adequately controlled before enrolment in the preceding trial.~3. failure to respond to six weeks treatment with Amlodipine 5 mg in the run-in period of the preceding trial.~Exclusion Criteria:~1. pre-menopausal women who are not surgically sterile; or are nursing or pregnant; or are not practising acceptable means of birth control or do not plan to continue using acceptable means of birth control throughout the study~2. development of any medical condition in the preceding trial that in the investigator's opinion could be worsened by treatment with either Telmisartan 40 mg/Amlodipine 5 mg or Telmisartan 80 mg/Amlodipine 5 mg~3. discontinuation from the preceding trial because of any adverse event or any other reason~4. known or suspected secondary hypertension~5. mean seated Systolic Blood Pressure =\> 180 mmHg and/or mean seated Diastolic Blood Pressure =\> 120 mmHg at any visit

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).